The AHA’s Health Research & Educational Trust affiliate and the Centers for Disease Control and Prevention today announced a three-year initiative to improve the implementation of infection prevention and control efforts in U.S. hospitals. The project will work with state hospital associations, state health departments, the Centers for Medicare & Medicaid Services’ Quality Improvement Networks, AHA’s American Society for Healthcare Engineering affiliate and other partners to reduce central line-associated bloodstream infections, catheter-associated urinary tract infections, Clostridium difficile infections and methicillin-resistant Staphylococcus aureus infections in targeted acute care hospitals. “We welcome the opportunity to work with CDC on the important issue of infection prevention,” said Maulik Joshi, president of HRET and associate executive vice president of AHA. “This project will build on our national work that has successfully reduced CAUTI and CLABSI rates and improved patient care.”

Related News Articles

Headline
The Department of Health and Human Services July 23 announced it is recommending the removal of thimerosal from all U.S. flu vaccines. The announcement follows…
Headline
Carolyn Bogard, DNP, R.N., director of care coordination and palliative care at El Camino Health, talks about her system’s use of data to harness the passion…
Headline
The Food and Drug Administration has identified a Class I recall of certain lots of Medline Industries Craniotomy Kits containing recalled Codman…
Headline
Hartford HealthCare in Hartford, Conn., will receive the 2025 AHA Quest for Quality Prize as a result of their sweeping transformation over the past decade —…
Headline
A Q&A in the July edition of AHA Trustee Insights features leaders from Winchester Hospital in Massachusetts discussing the importance of board members…
Headline
To help hospitals across the country improve sepsis care, the Centers for Disease Control and Prevention created the Hospital Sepsis Program Core Elements,…